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Abstract
We have demonstrated that the renal endonuclease DNaseI is up-regulated in mesangial
nephritis while down-regulated during progression of the disease. To determine the basis
for these reciprocal DNaseI expression profiles we analyse processes accounting for an
early increase in renal DNaseI expression. Main hypotheses were that i. the mesangial in-
flammation and secreted pro-inflammatory cytokines directly increase DNaseI protein ex-
pression in tubular cells, ii. the anti-apoptotic protein tumor necrosis factor receptor-
associated protein 1 (Trap 1) is down-regulated by increased expression of DNaseI due to
transcriptional interference, and iii. pro-inflammatory cytokines promote nuclear transloca-
tion of a variant of DNaseI. The latter hypothesis emerges from the fact that anti-DNaseI an-
tibodies stained tubular cell nuclei in murine and human lupus nephritis. The present study
was performed on human tubular epithelial cells stimulated with pro-inflammatory cytokines.
Expression of the DNaseI and Trap 1 genes was determined by qPCR, confocal microsco-
py, gel zymography, western blot and by immune electron microscopy. Results from in vitro
cell culture experiments were analysed for biological relevance in kidneys from (NZBxNZW)
F1 mice and human patients with lupus nephritis. Central data indicate that stimulating the
tubular cells with TNFα promoted increased DNaseI and reduced Trap 1 expression, while
TNFα and IL-1β stimulation induced nuclear translocation of the DNaseI. TNFα-stimulation
resulted in 3 distinct effects; increased DNaseI and IL-1β gene expression, and nuclear
translocation of DNaseI. IL-1β-stimulation solely induced nuclear DNaseI translocation. Tu-
bular cells stimulated with TNFα and simultaneously transfected with IL-1β siRNA resulted
in increased DNaseI expression but no nuclear translocation. This demonstrates that IL-1β
promotes nuclear translocation of a cytoplasmic variant of DNaseI since translocation clear-
ly was not dependent on DNaseI gene activation. Nuclear translocated DNaseI is shown to
be enzymatically inactive, which may point at a new, yet unknown function of renal DNaseI.
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Introduction
Lupus nephritis is a prototype immune complex disease where antibodies to dsDNA play a
central role [1–3]. Deposition of chromatin fragment-anti-dsDNA antibody complexes has
been shown to be one of the core factors that impose progressive renal inflammation [4–9].
The origin of chromatin exposed in these immune complexes has for a long time been dis-
cussed but consensus has not been reached. The same lack of international consensus relates to
how anti-dsDNA antibodies really exert their pathogenic potential [10].
Recent results from our studies on the pathogenesis of murine and human lupus nephritis
have demonstrated that DNaseI, representing> 80% of the total renal endonuclease activity
[11,12] is profoundly down-regulated when mild or clinically silent mesangial nephritis pro-
gresses into severe membrano-proliferative lupus nephritis [13–15].
DNaseI executes the initial degradation of whole chromatin in context of apoptosis and ne-
crosis [16,17]. This is important to perceive, as the initial chromatin degradation is a prerequi-
site for other secondary endonucleases to digest the chromatin fragments into small oligo-
nucleosomes (see e.g. [16,17] for review).
With low renal DNaseI enzyme activity, chromatin is not appropriately fragmented and is
instead transformed into secondary necrotic chromatin unmasked from apoptotic blebs (re-
viewed in [18,19], see also [20–22]). Once exposed, these chromatin fragments may bind glo-
merular basement membranes (GBM) and the mesangial matrix [5,23] at high affinity as
demonstrated in vitro by surface plasmon resonance analyses [6]. Whether chromatin is tar-
geted by anti-dsDNA antibodies in situ or before chromatin accumulates in membranes and
matrices is not yet determined. However, complex formation of antibodies and chromatin frag-
ments seems to be a central event in progressive lupus nephritis [10]. Thus, to understand the
transcriptional and molecular basis for progressive lupus nephritis means to comprehend the
mechanisms of renal DNaseI regulation in context of mesangial nephritis.
Despite the fact that DNaseI was isolated and characterized more than 60 years ago by
McCarty et al. [24], the basic mechanisms responsible for regulation of the enzyme expression
is not resolved. Due to previous observations that renal DNaseI has a tendency to be increas-
ingly expressed during mesangial nephritis [25], we propose the simple hypothesis that pro-
inflammatory cytokines might up-regulate the renal DNaseI enzyme. In addition, since the
anti-apoptotic tumor necrosis factor receptor-associated protein 1 (Trap 1) [26–28] may be in-
versely co-regulated by a process denoted transcriptional interference [29], up-regulation of
DNaseI may in fact down-regulate Trap 1 in mesangial nephritis, and vice versa as has been in-
dicated in studies in (NZBxNZW)F1 mice [29].
Transcriptional interference is defined as a direct negative impact of transcription of one
gene on transcription of a second anti-sense gene provided that the two genes overlap with
each other. This process implies that if one of the genes is increasingly transcribed, the opposite
gene is blocked for transcription.
Trap 1 is encoded in the opposite direction of DNaseI on the opposite DNA strand, and the
transcripts overlap in their 3’ untranslated regions (3’UTR) (see http://genome.ucsc.edu/, see
[30] for gene maps). In this type of gene organisation, it is likely that co-expression of the genes
will be precluded by transcriptional interference [31,32]. If we take this information into con-
sideration this allows us to assume that expression of renal DNaseI and renal Trap 1 are i. both
blocked if both receive a transcriptional stimulus; ii. that one gene is blocked for transcription
if the other is transcribed in response to specific stimuli.
The hypotheses that incited this study were therefore three-fold; i. the mesangial inflamma-
tion induces an early secretion of pro-inflammatory cytokines which directly increase DNaseI
protein expression in tubular cells; ii. the anti-apoptotic protein Trap 1 is down-regulated as a
Nuclear DNaseI Translocation in Renal Tubular Cells
PLOS ONE | DOI:10.1371/journal.pone.0129485 June 11, 2015 2 / 22
consequence of increased transcription of the DNaseI gene through transcriptional interfer-
ence of the two genes; iii. up-regulation of DNaseI gene expression simultaneously translocates
a variant of DNaseI into the nucleus. The latter hypothesis is based on published results (see
e.g. [33]) that DNaseI can be found in cell nuclei in different tissue. The mechanism and bio-
logical meaning of translocated DNaseI is not understood, may have impact in nuclei beyond
its endonucleolytic activity in context of apoptosis (present study).
The data demonstrate that DNaseI is up-regulated in human renal proximal tubule epithelial
cells (RPTEC) in response to TNFα and hypoxia, and at the same time, Trap 1 protein expres-
sion is reduced in a possible accordance with the proposed gene interference regulation of the
two genes. However, an inhibition of IL-1β by siRNA in TNFα-induced up-regulation of DNa-
seI restores expression of Trap 1 indicating that DNaseI and Trap 1 are also regulated by other
processes than by a pure transcriptional interference alone. We also show that stimulation of
RPTEC with TNFα and IL-1β promotes translocation of DNaseI into the nuclei. However nu-
clear DNaseI translocation in response to these stimuli is fully an IL-1β-depended process and
TNFα translocates DNaseI into the nuclei indirectly through the effect of TNFα-induced up-
regulation of IL-1β. Notably, appearance of DNaseI in the nuclei of RPTEC was not accompa-
nied by apoptotic chromatin fragmentation or terminal deoxynucleotidyl transferase dUTP
nick-end labeling (TUNEL) positive nuclei. These data strongly indicate that DNaseI has (an-)
other yet undetermined function(s) than just the endonucleolytic activity linked to cell death.
Materials and Methods
Ethic statements
The mouse study was approved by The National Animal Research Authority (NARA) (approv-
al ID: 07/11167, ID-178). A coherent analysis on renal biopsies taken from patients with lupus
nephritis was approved by The Scientific Ethical Committee, Copenhagen, Denmark ((KF) 01-
2006-7214). Informed written consent was given by the patients.
Murine and human tissue samples
Female (NZBxNZW)F1 (BW) and female age-matched BALB/c mice were purchased from Jack-
son Laboratory, Bar Harbor, Main, USA. Mice were euthanized by CO2 suffocation. Renal tissue
was collected every second week from the age of four weeks until development of end-stage dis-
ease in BWmice, clinically defined when severe proteinuria developed (20 g/L), as described
[25]. Included in this study are 5 mice from the pre-nephritic mice (Group 1, having no glomeru-
lar deposits of chromatin or IgG), 5 mice with mesangial nephritis (Group 2, having mesangial
deposits of chromatin-IgG complexes), and 5 mice with end-stage disease (Group 3, with depos-
its of chromatin-IgG complexes in mesangium and in glomerular basement membranes
(GBM)). Renal biopsies from patients, taken for diagnostic purposes, were classified according to
the International Society of Nephrology/Renal Pathology Society (ISN/RPS) [34], and used for
baseline observations on expression of DNaseI and Trap 1, and on nuclear DNaseI. Entry criteria
were fulfilment of the ACR classification criteria for SLE and clinical indication for renal biopsy.
As renal control samples included in this study, we collected morphologically unaffected
cortical tissue immediately after kidney extirpation in context of surgical treatment of renal
cancer. Procedure for collection of renal tissue is described in details [29].
Proteins and antibodies
The recombinant proteins used in this study are human TNFα (T6674), purchased from Sigma
Aldrich (St. Louis, Missouri, USA), while human IL-1β (201-LB 1), IL-6 (206-IL), IL-10 (217-IL-
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005) and human IFNγ (285-IF-100) were from R&D systems (Minneapolis, USA). Trap1 recom-
binant protein (H00010131-P01) was obtained from Abnova (Taipei, Taiwan) and used as refer-
ence protein in western blot analysis. Human recombinant DNaseI was obtained from AH
diagnostics, (Oslo, Norway) and was used as the control endonuclease enzyme in gel zymogra-
phy and reference protein in western blot. Caspase 3 control cell extracts (untreated and cyto-
chrome c treated Jurkat cells) were obtained from cell signaling technology (Boston, USA). The
following antibodies were used in this study: rabbit anti-DNaseI (sc30058), goat anti-Trap 1 (sc-
69289) and rabbit anti-histone H1 (sc10806) antibodies from Santa Cruz (Texas 75220 U.S.A);
rabbit anti-DNaseI (ab113241) antibodies from Abcam (Cambridge, UK); rabbit anti-DNaseI
(LS-B4846/31015), mouse anti-caspase 3 antibodies from LifeSpan Biosciences, cleaved caspase 3
antibody (9661) from Cell Signalling technology (Seattle, USA) and rabbit anti-actin antibody
(A2066) was from Sigma-Aldrich (St. Louis, MO). Alexa 595-conjugated anti-rabbit IgG and
Alexa 488-conjugated anti-goat IgG secondary antibodies were from Santa Cruz Biotechnology.
Horseradish peroxidase- (HRP-) conjugated rabbit anti-goat IgG, and goat anti-rabbit IgG were
purchased from Invitrogen (California, USA) for western blot studies.
Cell culture experiments
RPTEC (Clontec, Lonza, Basel, Switzerland) were grown in Clontec REGM BulletKit (CC-
3190) containing renal epithelial cell basal medium with the following growth supplements:
hEGF, Hydrocortisone, Epinephrine, Insulin, Triiodothyronine, Transferrin, GA-1000, and
fetal bovine serum at 37°C in 95% humidified air and 5% CO2. The cells were grown to 80%
confluence and were stimulated with TNFα (2.5, 5, 10, 20ng/ml), IFNγ (12.5, 25, 50, 100ng/
ml), IL-β1 (1.25, 2.5, 5, 10ng/ml), IL-6 (5, 10, 20ng/ml), and IL-10 (5, 10, 20ng/ml). The cells
were harvested at 12, 24, 48 hrs and analysed for DNaseI and Trap 1 mRNA and protein ex-
pression levels and for intracellular location (whether cytoplasmic or nuclear) of expressed pro-
teins by semi-quantitative western blots, and by confocal microscopy. For experimental
validation of responses to stimuli in RPTEC, known responder molecules were analysed by
qPCR (see Table 1 in Results).
Exposure of RPTEC to hypoxia
RPTEC were incubated under normal condition (control experiment) and in hypoxia condi-
tion (2% O2) using HeraCell 150i CO2 incubator (Thermo scientific, Massachusetts, USA).
Cells were harvested at 3, 6, 8, 14, 24, 36, 48 and 72 hrs respectively and analysed for DNaseI
and Trap 1 mRNA and protein expression.
Short interference RNA (siRNA) transfection
In this study, 2x105 cells/well in 6-well dishes and 2x104 cells/well in confocal plates were seed-
ed 24 hrs before transfection. After 24 hrs the media was removed and transfection was pro-
ceeded with fresh media containing 20ng/ml TNFα without and with 20 nM smart pool IL-1β
siRNA (Dharmacon) using Lipofectamine 2000 (Invitrogen). The cells were harvested after 48
hrs after transfection and analysed for IL-1βmRNA and protein expression, and for nuclear
DNaseI translocation. siRNA against P62 was used as a positive control for transfection in
separate wells.
RNA isolation and cDNA synthesis
Total RNA from the stimulation experiments was isolated using TRIzol (Invitrogen, CA, US)
as described by the manufacturer. The quality and concentration of extracted RNA were
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determined spectrophotometrically by Nano Drop (Nano Drop technologies, Wilmington,
USA). RNA samples were reverse-transcribed with random primers using High Capacity
cDNA Reverse Transcription kit (Applied Bio Systems, Foster City, USA).
Gene expression analyses
Quantitative real time PCR (qPCR) was performed using ABI Prism 7900HT Sequence Detec-
tion System (Applied Bio Systems). Pre-designed FAM-labeled gene expression assays (Ap-
plied Bio Systems) were used in this study. The accession numbers for these primer-probes are
given in Table 2. TATA binding protein (TBP) was used as endogenous control. The relative
expression levels were calculated using the ddCT method. Murine data are given as fold change
compared with transcription in 8-weeks old control (BALB/c) mice.
Western blot
For western blot analysis, RPTEC were harvested in lysis buffer (40mMTris, 2mM CaCl2, 2mM
MgCl2, 0.2% Triton X-100 pH 7.6) or 10 mg of murine kidney was homogenized and cleared
by centrifugation in the same buffer as described [14]. Samples were stored at -80°C. Protein
concentration was determined using BCA assay kit as recommended by the manufacturer
(Pierce Biochemicals, IL, US). Approximately 10μg normalized protein per well was loaded
onto a 4–12% Nu PAGE Bis-Tris gel (Invitrogen). SDS/PAGE and western blotting were per-
formed according to standard procedures. Membranes were blocked with 5% (w/v) skimmed
milk and probed with the relevant primary antibodies. After incubation with a HRP-conjugat-
ed goat anti-rabbit IgG or a rabbit anti-goat IgG antibody (Invitrogen), binding was assayed by
chemiluminescence detection. Determination of molecular weight was done using MagicMark
XP molecular weight markers (Invitrogen). Western blot of actin was included to ensure equal
loading of the samples onto the gel.
Table 1. Gene expression analysis of published responses to cytokines stimulation of RPTEC#.
Cytokines used for stimulation of RPTEC Responder parameters§ in RPTEC
MMP2 MMP9 IL-6 IL-10 TNFα IL-1β
TNFα (20ng) 0.65 (±0.08) ns 152 (±31.3) *** 9.2 (±1.3) *** 1.6 (±0,2) ns 60.4 (±6.9) *** 5.0 (±1.0) **
L-1β (2.5ng) 2.8 (±1.2) ns 8.7 (±2.2) * 22.7 (±3.5) ** 449.9 (±60,8) *** 8.2 (±3.3) ns 39.1 (±10.1) *
IFNγ (50ng)¶ 0.7 (±0.02) ns 1.8 (±0.9) ns 2.3 (±0.6) ns Not detected 0.3 (±0.1) ns 7.9 (±2.6) ns
IL-6 (20ng) 0.6 (±0.1) ns 2.1 (±0.1) ns 0.7 (±0.05) ns 18.9 (± 6,9)* 0.6 (±0.2) ns 0.7 (±0.1) ns
IL-10 (20ng) 0.8 (± 0.07) ns 0.3 (±0.07) ns 1.0 (±0.2) ns Not Detected 0.5 (±0.2) ns 6.5 (±4.8) ns
#Data are given as fold change (± SD) compared with expression in non-stimulated RPTEC.




ns: no significant up-regulation.
§Quality control analysis in RPTEC stimulated with various cytokines. The expected response for each stimulation: TNFα up-regulates MMP9 [52,53], IL-6
[54,55] and IL-1β [36]. Stimulation of RPTEC with IL-1β up-regulates IL-10 [56], IL-6 stimulation up-regulates IL-10 [57] and IL-10 stimulation up-regulates
IL-1β though this was not significant in these experiments.
¶ IFNγ up-regulated CXCL10 to 1000 fold in RPTEC [58].
One-way ANOVA with Dunett post hoc test was used to assess the differences in mRNA expression levels with all concentrations used for each cytokine
to stimulate RPTEC when compared to non-stimulated cells. In the table the results are shown only for one concentration of each cytokine.
doi:10.1371/journal.pone.0129485.t001
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Nuclear and cytoplasmic extraction of proteins from RPTEC
Nuclear and cytoplasmic extracts from RPTEC were isolated using NE-PER Nuclear and Cyto-
plasmic Extraction kit according to suppliers’ instruction (Fisher scientific, USA). Briefly
1x106 cells from both resting and TNFα (20 ng/ml) stimulated RPTEC were harvested using a
Trypsin/EDTA buffer (Clonetech). The washed cells were incubated with CER reagent I on ice
for 10 min, with CER reagent II for 1 min and centrifuged at 15000 x g for 5 min. The superna-
tant contained the clean cytoplasmic extract. The pellet was re-suspended in NER reagent and
incubated on ice for 40 min with vortexing every 10 min. Then the cells were centrifuged at
23000 x g for 10 min and the collected supernatant contained the nuclear extract. Both cyto-
plasmic and nuclear extracts were stored at -80°C until use. Control analyses demonstrated
that histone H1 is absent in the cytoplasmic, but present in the nuclear fraction (see Results).
DNA isolation and electrophoretic analysis
Total DNA was isolated from RPTEC without and with TNFα- (20ng/ml) stimulation for 48
hrs by using GenElute Mammalian Genomic DNAMiniprep kit from Sigma Aldrich
(St. Louis, Missouri, USA). One μg of total DNA was size-fractionated by gel electrophoresis in
1.5% SeaKem LE Agarose gel from Lonza (Rockland, ME USA) in Tris-acetate-EDTA buffer
and visualized under UV illuminator using staining with Nucleic Acid Gel Stains GelRed 730–
2958 (VWR International, Oslo, Norway). The 100 bp DNA ladder from New England BioLabs
Inc (MA, USA) was used to determine size distribution similar to an apoptotic 200-bp DNA
ladder. DNA isolated by EZ1 DNA Tissue Kit (Qiagen, Bergen, Norway) from murine spleen
incubated 6 hrs in 5 μM camptothecin purchased from Sigma-Aldrich (St. Louis, MO) was
used as a positive control for apoptotic DNA fragmentation.
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DNaseI gel zymography
DNaseI enzymatic activity in murine kidney homogenates was analysed by protein separation
in 10% SDS-polyacrylamide gels containing 40μg/ml heat–denatured salmon sperm DNA
(Invitrogen Corp, Carlsbad, CA) as described [25]. After electrophoresis, proteins in the gel
were washed and re-natured in DNaseI reactivation buffer (20 mM Tris/HCl, pH 7.6, 5 mM
CaCl2, 5 mMMgCl2) for 24 hrs, and stained with Nucleic Acid Gel Stains GelRed 730–2958
(VWR International, Oslo, Norway). The gel was visualized under UV illuminator and the en-
zyme activity was related to the molecular weight of the recombinant endonuclease DNaseI in
the gel. Collection of kidney samples for zymography was performed as described before [25].
Confocal microscopy
RPTEC were seeded in 8 well μ-Slide plates (IB80826) from Ibidi (Munich, Germany). The
cells were fixed in 4% paraformaldehyde in PBS for 10 min on ice. The cells were permeabilized
using 0.1% Triton X-100 (VWR International) in PBS for 5 min, followed by blocking in 3%
BSA for 30 min and incubation with anti-Trap 1 and anti-DNaseI antibodies for 60 min and
subsequently with Alexa 488 anti-goat IgG and Alexa 595 anti-rabbit IgG antibodies for Trap1
and DNaseI, respectively, for 30 min, as described before [29]. The protein expression patterns
were analysed using Zeiss-LSM510 Meta confocal microscopy. DAPI counter stain (Abbott
Molecular Inc, USA) was used to stain nuclei.
TUNEL Assay
The TUNEL kit was purchased from Roche (Indiana, USA) and the assay was performed ac-
cording to the manufacturer’s instruction. Briefly, sham-stimulated and TNFα-stimulated
RPTEC cells were fixed in 4% paraformaldehyde in PBS for 10 min on ice. The cells were per-
meabilized using 0.1% Triton X-100 (VWR International) in PBS for 5 min. The cells were sub-
sequently treated with TUNEL Mix containing TUNEL label (11767291910; Roche) and the
terminal deoxynucleotidyl transferase enzyme (11767305001; Roche), and incubated at 37°C
for 1hr. The cells were washed with 1xPBS and nuclei were stained by DAPI and subsequently
subjected to confocal microscopy using the Carl Zeiss LSM 700 confocal microscopy. As a posi-
tive control in the TUNEL assay, RPTEC were exposed to 10U recombinant DNaseI to induce
single-stranded (TUNEL-positive) nicks, and the negative control was represented by TUNEL
in absence of terminal deoxynucleotidyl transferase.
IHC Analysis
Immunohistochemical staining of DNaseI was performed as described in detail [14] using En-
Vision+ System–HRP (DAB) (Dako Norge, Oslo).
Immune electron microscopy
Immune electron microscopy (IEM) was performed to detect IgG deposits in glomerular ma-
trices and membranes [25] and to detect tubular cell expression patterns of Trap 1 and DNaseI
in renal ultrathin sections from (NZBxNZW)F1 mice exactly as described recently [29].
Mass spectrometry
Nuclear and cytoplasmic proteins from RPTEC lysates were loaded onto 4–12% NU-PAGE
SDS PAGE and the gel was stained with commassie blue. The gel was then destained and the
respective bands were cut and the gel pieces were subjected to gel reduction, alkylation, and
tryptic digestion using 6 ng/μl trypsin (V511A, Promega, Wisconsin, USA) [35]. OMIX C18
Nuclear DNaseI Translocation in Renal Tubular Cells
PLOS ONE | DOI:10.1371/journal.pone.0129485 June 11, 2015 7 / 22
tips (Varian, Inc., Palo Alto, CA, USA) was used for sample clean up and concentration. Pep-
tide mixtures containing 0.1% formic acid were loaded onto a Thermo Fisher Scientific EASY-
nLC1000 system and EASY-Spray column (C18, 2μm, 100 Å, 50μm, 15 cm). Peptides were
fractionated using a 2–100% acetonitrile gradient in 0.1% formic acid over 50 min at a flow
rate of 250 nl/min. The separated peptides were analysed using a Thermo Scientific Q-Exactive
mass spectrometer. Data were collected in a data dependent mode using a Top10 method. The
raw data were processed using the Proteome Discoverer 1.4 software. The fragmentation spec-
tra were searched against the Swissprot SwissProt_2011_12 database using an in-house Mascot
server (Matrix Sciences, UK). Peptide mass tolerances used in the search were 10 ppm, and
fragment mass tolerance was 0.02 Da. Peptide ions were filtered using a false discovery rate
(FDR) set to 1% for peptide identifications.
Statistics
Data are presented as mean of 3 parallels (± SD). An unpaired t-test was performed to test dif-
ferences between IL-1β siRNA transfected and non-transfected cells and a one-way ANOVA
with Dunett post hoc test was performed to compare each time point at different concentra-
tions of cytokines to non-stimulated cells. For each parameter; p<0.05 was considered signifi-
cant. All observations were included and Spearman was used for significance testing.
Results
Characterization of renal DNaseI and Trap 1 expression patterns in
(NZBxNZW)F1 mice during progressive lupus nephritis
Baseline data for the BWmice included in this study have been published recently [25]. These
mice are grouped according to morphology of the kidneys as determined by immune electron
microscopy. Fig 1A demonstrates that Group 1 mice have no deposits of immune complexes in
glomeruli; Group 2 mice have chromatin-IgG complex deposits, seen as electron dense structures
(EDS) [5,25] in the mesangium; Group 3 mice have EDS in the mesangium and within the GBM.
Individual mice from each group were further analysed for renal expression of DNaseI and Trap
1 by IEM. Fig 1B demonstrates that in Group 1 and Group 2 kidneys, DNaseI and Trap 1 are
moderately expressed, while in Group 3 kidneys DNaseI expression could not be detected. Ex-
pression of Trap 1 in Group 3 mice was conversely strong compared with expression in Group 1
and Group 2 mice. As demonstrated in Fig 1C (left panel), renal DNaseI mRNA varied consider-
ably in mice analyzed at various stages of the disease progression (n = 5 per group). Notably,
renal DNaseI mRNA levels were particularly high in Group 2 compared with the levels in Group
1 and Group 3 BWmice. In Group 3, DNaseI mRNA levels were hardly detectable (Fig 1C,
[25]). In the right panel in Fig 1C, DNaseI mRNA levels are demonstrated in individual mice
from Groups 1–3 (n = 3 per group). Of particular interest is the observation of high to very high
DNaseI levels in some Group 2 mice. Coherent results were obtained when comparing DNaseI
mRNA levels and DNaseI enzyme activity (Fig 1C and 1D, respectively). This may mean that in
Group 2 kidneys with mesangial nephritis, the inflammatory milieu is a candidate factor to ex-
plain early up-regulation of DNaseI. This hypothesis is subsequently tested in RPTEC by con-
trolled in vitro experiments. Renal DNaseI zymography data from all mice sacrificed every
second week from 4–40 weeks as part of a longitudinal study is recently published [25].
Characterization of DNaseI protein expression pattern in resting RPTEC
Published data on sub-cellular location of DNaseI are discrepant. Some describe DNaseI in the
cytoplasm [16], others indicate a nuclear position of DNaseI [33]. In order to firmly analyse
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how pro-inflammatory cytokines affect DNaseI expression in RPTEC, we first characterized
DNaseI expression pattern by immunofluoresence and western blot in resting RPTEC. To per-
form the analysis, we tested three anti-DNaseI antibodies from different companies: Abcam,
LifeSpan and Santa Cruz. All results with antibody from Abcam were reproduced with anti-
body from LifeSpan (Fig 2A and 2B respectively), while the antibody from Santa Cruz gave a
different pattern in confocal microscopy as well as in western blot (S1A Fig) and were therefore
excluded from this study.
Immunofluorescence analysis of DNaseI in resting RPTEC demonstrated staining in cyto-
plasm that was almost absent in the nuclei (Fig 2A and 2B). Western blot analysis of total cell
lysate from RPTEC demonstrated two main bands recognized by the Abcam and the LifeSpan
Fig 1. Renal expression of DNaseI and Trap 1 in (NZBxNZW)F1mice during development of lupus
nephritis.Mice were divided into 3 groups according to localization of electron dense structures (EDS)
containing IgG (as traced by 5nm gold particles) in glomeruli as determined by immune electron microscopy
(A). Pre-nephritic mice (Group 1) with no presence of EDS in glomeruli; mice with mesangial nephritis (Group
2) present EDS in the mesangium only; mice with membrano-proliferative nephritis (Group 3) have EDS both
in the mesangium and in GBM (A). Expression patterns of DNaseI and Trap 1 were analysed by immune
electron microscopy in Group 1–3 mice (B). DNaseI and Trap 1 were co-expressed in tubular cells in kidneys
of Group 1 and Group 2 mice, while DNaseI staining was virtually absent in tubular cells in kidneys from
Group 3 mice, while expression of Trap 1 was increased in these cells. The staining patterns were reflected
by mRNA levels of renal DNaseI (C). In the left panel (C) average mRNA levels (±SD) are demonstrated in
BWmice belonging to different groups (n = 5 per group). In the right panel (C), individual data on DNaseI
mRNA levels in BWmice from Groups 1–3 (n = 3 per group) are demonstrated and compared with DNaseI
gel zymography data (D). Renal DNaseI zymography data from all mice sacrificed every second week from
4–40 weeks are published in [25]. Significances: *<0.05; ***<0.0005.
doi:10.1371/journal.pone.0129485.g001
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anti-DNaseI antibodies: a strong 40 kDa and a weak 55 kDa band (Fig 2A and 2B). The same
results were observed in western blot analysis of kidney homogenates from BWmice (Fig 2C).
To analyse if all bands were enzymatically active, DNaseI zymography was performed on mu-
rine kidney samples (Fig 2D). Only the 40 kDa band possessed DNaseI enzyme activity in the
kidney samples. No enzymatic activity was found in the area corresponding to molecular
weights above 40 kDa, and particularly not around 55 kDa (Fig 2D).
In order to confirm that the 40 kDa and 55 kDa bands indeed represented DNaseI protein
variants, mass spectrometry analysis of all bands in RPTEC lysates detected by the anti-DNaseI
antibodies was performed. The data demonstrated that anti-DNaseI antibodies specifically de-
tect a DNaseI protein in all band regions defined by western blot (Table 3). As demonstrated in
the Table 3, the gel region corresponding to cytoplasmic 40 kDa DNaseI contained 2 peptides
Fig 2. Characterization of DNaseI protein expression pattern in resting tubular cells and (NZBxNZW)
F1 kidney homogenates. Patterns of immunofluorescence staining of human renal proximal tubule epithelial
cells (RPTEC) and western blot analyses of RPTEC lysates are demonstrated (A and B). Anti-DNaseI
antibodies from Abcam (A) and LifeSpan (B) predominantly stain cytoplasm and recognize two dominant
bands: a strong 40 kDa band and a weaker 55 kDa band by western blot (A, B). The same bands were
detected in kidney homogenates isolated from pre-nephritic BWmice Group 1 (C). As demonstrated by
zymography only the 40 kDa bands possessed DNaseI enzyme activity while no enzymatic activity was
found in area corresponding to the 55 kDa band. Human recombinant DNaseI was used as a control for both
western blot analysis and DNaseI zymography.
doi:10.1371/journal.pone.0129485.g002
Table 3. Mass spectrometry analysis of renal tubular cell lysates size-fractionated by SDS gel electrophoresis.
Gel regions as MW spans that
are subjected to mass
spectrometry
Bands recognized by anti-
DNaseI antibody on western
blot
Presence of DNaseI protein
verified by mass
spectrometry













38–40 kDa No bands 40 kDa No Yes Not detected LLDNLNQDAPDTYHYVVSEPLGR
YDIALVQEVR
50–55 kDa 52 kDa 55 kDa Yes Yes YDIALVQEVR LLDNLNQDAPDTYHYVVSEPLGR
doi:10.1371/journal.pone.0129485.t003
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recognized also in the nuclear fraction of 52 kDa (YDIALVQEVR) and in the cytoplasmic frac-
tion of 55 kDa (LLDNLNQDAPDTYHYVVSEPLGR) respectively.
The renal mRNA expression levels of pro-inflammatory cytokines in
progressive murine lupus nephritis
Analyses by qPCR were performed to quantify renal mRNA expression levels of pro-inflamma-
tory cytokines in different stages of lupus nephritis in BWmice (Fig 3A). The mRNA levels of
TNFα and IL-1β were significantly increased in kidneys from Group 2 and Group 3 mice when
compare with Group 1. While mRNA levels of TNFα in Group 2 and 3 did not markedly differ,
expression of IL-1β was significantly increased in Group 3 compared to Group 2. Expression
levels of INFγ were stable, while levels of IL-6 and IL-10 varied considerably in kidneys from
individual mice within each group. The differences of the latter between the groups were not
statistically significant. However, a statistical significance was found for mRNA levels of IL-10
when comparing Group 3 with Group 1 (Fig 3A).
Fig 3. Pro-inflammatory cytokines profile in lupus nephritis and their effect on DNaseI expression in
tubular cells.Renal mRNA expression of pro-inflammatory cytokines in (NZBxNZW)F1 mice during
development of lupus nephritis demonstrated in A. The data demonstrate significant up-regulation of TNFα
and IL-1β in Group 2 and Group 3 mice when compared to Group 1. IL-10 mRNA levels were significantly
increased in Group 3 BWmice compared to Group 1. One-way ANOVA with Dunett post hoc test was
performed to assess the difference in gene expression between the groups when compared to group 1 and 2.
Effect of pro-inflammatory cytokines and hypoxia on DNaseI and Trap 1 mRNA levels in human renal
proximal tubule epithelial cells (RPTEC) are shown in B. Significant elevation of DNaseI mRNA levels in
RPTEC was found only upon TNFα stimulation and stress by hypoxia (B). No change in DNaseI gene
expression was observed when RPTEC were stimulated by IL-1β, IFNγ, IL-6 or IL-10 (B). Trap 1 mRNA was
significantly reduced after stimulations with IL-1β and hypoxia. Significances: *<0.05; **<0.005;
***<0.0005.
doi:10.1371/journal.pone.0129485.g003
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The effect of pro-inflammatory cytokines on DNaseI mRNA expression
in RPTEC
To analyse whether pro-inflammatory cytokines can affect expression levels of DNaseI in tubu-
lar cells, in vitro experiments applied to RPTEC were performed. The mRNA levels of DNaseI
from RPTEC stimulated for 48 hrs with pro-inflammatory cytokines or stressed by hypoxia are
demonstrated in Fig 3B. As is evident, TNFα and hypoxia significantly up-regulated DNaseI
mRNA levels in RPTEC. Similar results were obtained after stimulation with TNFα for 24 hrs
(S2A and S2B Fig, for protein and mRNA expression, respectively). In contrast, IL-1β, IFNγ,
IL-6 and IL-10 had no influence on DNaseI gene expression in the cells (Fig 3B). Except for IL-
1β and hypoxia, Trap1 mRNA levels were largely un-affected in the stimulated RPTEC, in con-
trast to reduced protein levels in response to TNFα (see below).
Renal DNaseI protein expression and sub-cellular location in lupus
nephritis and in RPTEC stimulated with pro-inflammatory cytokines
Analyses of renal DNaseI expression in murine and human lupus nephritis demonstrated that
the cellular location of DNaseI differed during development of the disease. For example, in
non-lupus kidneys DNaseI was expressed almost exclusively in cytoplasm, while in kidneys as
having human lupus nephritis ISN/RPS class IV, DNaseI was abundantly present in tubular
nuclei (Fig 4A). No morphological changes corresponding to apoptosis was observed in tubular
cells with DNaseI nuclear staining (Fig 4A).
To experimentally analyse whether an inflammatory milieu may affect localization of the
cellular DNaseI, RPTEC were stimulated with pro-inflammatory cytokines or stressed by hyp-
oxia, and expression pattern and sub-cellular location of DNaseI was analysed by confocal mi-
croscopy (Fig 4B merged picture, green: anti-Trap 1 antibody, red: anti-DNaseI antibody). As
demonstrated in Fig 4B, stimulation of RPTEC with TNFα or IL-1β for 48 hrs promoted DNa-
seI translocation into the nuclei. The same results were obtained at 24 hrs of stimulation (S2A,
S2B, S2C and S2D Fig for TNFα and IL-1β respectively). The nuclear translocation of DNaseI
reflected a specific process, since stressing the cells by hypoxia resulted in significant up-regula-
tion of DNaseI mRNA levels (Fig 3B) and protein expression (S3 Fig), but not in nuclear trans-
location of DNaseI. Similarly, stimulation of RPTEC with IFNγ, IL-6 and IL-10 had no
influence on DNaseI mRNA expression levels (Fig 3B) or sub-cellular protein location (Fig
4C). The experiments described here were validated by determination of known responses to
the individual cytokines used as stimulators (Table 1).
TNFα stimulation of RPTEC increases expression of DNaseI and
translocates DNaseI into the nucleus
RPTEC were stimulated for 24 hrs (S2A Fig) or for 48 hrs (Fig 5) by TNFα. In sham-stimulated
RPTEC the anti-DNaseI antibody (Abcam) predominantly stained cytoplasm but not the nu-
cleus (S2A Fig for 24h and Fig 5A for 48 hrs respectively, upper panels). In cells stimulated
with 20ng/ml TNFα the anti-DNaseI antibody stained more strongly in cytoplasm and dis-
tinctly stronger in the nucleus (S2A Fig for 24 hrs and Fig 5A for 48 hrs respectively, lower pan-
els). This nuclear translocation was consistent with an increased expression, not only of the 40
kDa protein, but also the approximately 55 kDa protein as demonstrated by western blot at 48
hrs of stimulation (Fig 5B). In agreement with data in Fig 1, Trap 1 expression was reduced
concomitant with increased DNaseI expression (Fig 5B, see below). In order to characterize the
sub-cellular origin of these proteins, we performed western blot analysis with anti-DNaseI anti-
bodies on nuclear and cytoplasmic fractions of RPTEC (Fig 5C). The data demonstrated
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presence of a very weak 52 kDa band in the nuclear fraction of un-stimulated RPTEC (Fig 5C)
but a very strong nuclear 52 kDa band after TNFα stimulation (Fig 5C). As is demonstrated,
the 52 kDa protein was distinctly different from the 55 kDa protein in size.
To confirm nuclear location of DNaseI after stimulation with TNFα, nuclei of RPTEC were
stained with DAPI (blue). As demonstrated in Fig 5A fluorescent signals from anti-DNaseI an-
tibody (red) and DAPI (blue) were co-localized in the nuclei of RPTEC. Furthermore, western
blot analysis of the histone H1 protein in the nuclear and cytoplasmic fractions of TNFα-stim-
ulated RPTEC cell lysates demonstrated that the 52 kDa DNaseI band was exclusively present
in the nuclear fraction that contained histone H1 (Fig 5D).
Nuclear translocation of DNaseI in RPTEC depends on the effect of IL-
1β
Translocation of DNaseI in the nuclei in RPTEC was demonstrated after stimulation with both
TNFα and IL-1β. While TNFα up-regulates DNaseI expression and promotes nuclear DNaseI
Fig 4. Sub-cellular location of DNaseI in lupus nephritis and in tubular cells stimulated with pro-
inflammatory cytokines. Immunohistochemistry analysis of renal DNaseI in a control human kidney sample
demonstrated that DNaseI was predominantly localized in cytoplasm and not in nuclei (A, left panel). In
human lupus nephritis the DNaseI was abundantly present in both cytoplasm and notably in nuclei (A, right
panel, arrows point at positively stained nuclei). In human renal proximal tubule epithelial cells (RPTEC)
DNaseI protein expression pattern was determined together with Trap 1 by confocal microscopy (B, green:
anti-Trap 1 antibody, red: anti-DNaseI antibody), only the merged pictures are shown. While resting cells
expressed DNaseI predominantly in cytoplasm, stimulation of RPTEC by TNFα and IL-1β resulted in nuclear
translocation of the protein (B). Interestingly, stress by hypoxia also resulted in increased expression of the
DNaseI protein but not in nuclear translocation (B). Nuclear translocation of DNaseI was notably not
observed after stimulation of RPTEC with IFNγ, IL-6 or IL-10 (C).
doi:10.1371/journal.pone.0129485.g004
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translocation (Figs 3B and 4B), IL-1β does not affect transcriptional or translational levels of
DNaseI expression in RPTEC (Fig 3B) but still promotes nuclear DNaseI translocation (Fig
4B). Since TNFα is known to up-regulate expression of IL-1β [36], confirmed here to be valid
also for tubular cells (Table 1), this opens for the possibility that TNFα translocates DNaseI
into the nuclei indirectly through the effect of TNFα-induced up-regulation of IL-1β. We
therefore transfected RPTEC with IL-1β siRNA and stimulated them at the same time with
20ng/ml of TNFα for 48 hrs (Fig 6A–6C). Although DNaseI expression was increased in TNF-
stimulated and IL-1β siRNA transfected cells nuclear translocation of DNaseI did not occur in
Fig 5. Cytoplasmic and nuclear DNaseI and Trap 1 expression in tubular cells after stimulation with
TNFα. Confocal microscopy of sham-stimulated human renal proximal tubule epithelial cells (RPTEC) (A,
upper panels), and cells stimulated with 20ng/ml of TNFα for 48 hrs (A, lower panels) was performed by using
anti-Trap1 antibodies (A, green) and by anti-DNaseI antibodies (A, red). No nuclear staining of DNaseI was
observed in sham-stimulation of the cells (A, upper panels). After stimulation of RPTEC with TNFα,
expression of DNaseI generally increased in staining intensity, and DNaseI translocated into the nucleus (A,
lower panels). Nuclear location of DNaseI was confirmed by co-staining with DAPI (A, blue). The data
demonstrate that DNaseI and DAPI were in confocus (violet in the merged picture, A, lower panel), thus
confirming that DNaseI indeed was translocated to the nucleus. Correspondingly, by western blots both the
40 kDa and the 55 kDa bands increased in response to increasing TNFα stimulation (0, 10, 20ng/ml TNFα)
(B). In the same cells, Trap 1 expression was reduced after TNFα stimulation, as determined by confocal
microscopy (A, lower panels versus upper panels, green staining) and by western blot (B). Nuclear and
cytoplasmic protein fractions were isolated from RPTEC after 48 hrs stimulation by TNFα (C). The 40 kDa
and 55 kDa bands were detected in cytoplasmic fraction (C, lane 1), while weak 52 kDa band was observed
in nuclear fraction of sham-stimulated RPTEC (C, lane 2). After 48 hrs stimulation with 20ng of TNFα, an
increased DNaseI expression in cytoplasm (C, lane 3) and remarkably strong expression of the 52 kDa
DNaseI in the nuclei was apparent (C, lane 4). Thus data from western blot analysis corresponded with data
from confocal microscopy with respect to TNFα-induced nuclear translocation of DNaseI. Only nuclear
fractions of RPTEC contained histone H1 protein as shown in D, confirming controlled separation of nuclear
and cytoplasmic fractions in the cells. Actin was used as a loading control in all western blot analyses.
doi:10.1371/journal.pone.0129485.g005
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cells where expression of IL-1β was inhibited by siRNA (Fig 6A, lower panels). In TNFα stimu-
lated RPTEC cells in absence of IL-1β siRNA transfection, DNaseI was notably translocated
into the nuclei (Fig 6A, middle panels). In Fig 6D, a positive control for transfection is demon-
strated in separate RPTEC cells with p62 siRNA. This treatment reduced the p62 mRNA
significantly.
IL-1β-dependent nuclear DNaseI translocation does not promote
chromatin fragmentation, activation of caspase 3, or single-strand DNA
cuts as determined by the TUNEL assay
DNaseI can translocate into the nuclei upon apoptotic stimuli where it performs its canonical
function- chromatin fragmentation [33,37]. However in RPTEC stimulated with TNFα or with
IL-1β, nuclear translocation of DNaseI was not accompanied by induction of an apoptotic pro-
cess or DNA degradation. As demonstrated in Fig 7A no activated caspase 3 was detected by
western blot analysis in cell lysates of TNFα stimulated RPTEC. No DNA fragmentation was
found in TNFα stimulated RPTEC with nuclear DNaseI location as shown by DNA agarose gel
and by negative TUNEL assay (Fig 7B and 7C respectively). These data are in accordance with
Fig 6. Effect of IL-1β siRNA on nuclear DNaseI translocation in RPTEC stimulated with TNFα. Confocal
microscopy of sham-stimulated RPTEC (A, upper panels), cells stimulated with 20ng/ml of TNFα for 48 hrs
(A, middle panels) and cells transfected with IL-1β specific siRNA and stimulated with TNFα for 48 hrs was
performed by using anti-Trap1 antibodies (A, green) and by anti-DNaseI antibodies (A, red). While incubation
of RPTECwith TNFα induced nuclear DNaseI translocation (A, middle panels), in RPTEC transfected with IL-
1β siRNA and then stimulated with TNFα this did not result in translocation of DNaseI into the nuclei (A, lower
panels). mRNA levels of DNaseI and IL-1β were increased in non-transfected RPTEC after stimulation with
TNFα (B). Transfection with IL-1β siRNA inhibited mRNA level of IL-1β in RPTEC (C) but did not affect an
increase in DNaseI gene expression induced by TNFα stimulation (C). Efficiency of the transfection
procedure in RPTEC was controlled by transfection of P62 siRNA. As demonstrated in D, mRNA level of P62
was markedly decreased in transfected cells. Significances: *<0.05; **<0.005.
doi:10.1371/journal.pone.0129485.g006
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gel zymography analyses of murine nephritic kidneys, showing no endonucleolytic activity
above 40 kDa (Fig 2D). These data indicate that DNaseI located in the nuclei after TNFα or IL-
1β stimulations has another function than to serve as an endonucleolytic enzyme.
Trap 1 expression in RPTEC stimulated with pro-inflammatory cytokines
In order to determine whether expression of Trap 1 would be affected by increased DNaseI ex-
pression due to a proposed gene interference mechanism, we analysed expression of Trap 1
and DNaseI in RPTEC stimulated with pro-inflammatory cytokines. The mRNA level of Trap
1 was found to be down-regulated in RPTEC in response to IL-1β stimulation for 48 hrs (Fig
3B) and hypoxia. Notably, the data demonstrate reduced Trap 1 protein expression in RPTEC
upon TNFα stimulation for 48 hrs as shown by western blot analysis in Fig 5B and by confocal
microscopy (Fig 5A, green). In accordance with this we have demonstrated that DNaseI and
Trap 1 have an inverse protein expression pattern in BWmice (Fig 1B). Similarly, in RPTEC
stimulated with TNFα, all of the variant DNaseI bands are increasingly expressed, and, at the
same time, the Trap 1 protein expression is progressively reduced (Fig 5A and 5B). Interesting-
ly, reduced expression level of Trap 1 protein during TNFα stimulation (Figs 5A and 6A,
green) was restored when expression of IL-1β was simultaneously inhibited by IL-1β siRNA
transfection (Fig 6A, green). This harmonizes with the fact that TNFα induces up-regulation of
IL-1β in RPTEC (Table 1) and that IL-1β directly down-regulates Trap 1 mRNA (Fig 3B). It is
also indicating that the regulation of Trap 1 and DNaseI during TNFα and IL-1β stimulations
in the present cell experiments cannot be explained only by transcriptional interference related
to the direct antagonistic expression effects of these proteins.
Fig 7. Nuclear DNaseI translocation in RPTECwas not associated with caspase 3 activation or DNA fragmentation.Western blot analysis was
performed to detect presence of activated caspase 3 in cell lysates from RPTEC stimulated or non-stimulated with 20ng/ml of TNFα for 48 hrs (A). Resting
Jurkat cells or cytochrome c treated Jurkat cells were used as a negative and positive control for activated caspase 3 (A, lane 1 and 2, respectively). As
demonstrated in A, lane 4, TNFα-induced nuclear DNaseI translocation was not accompanied by activation of caspase 3 since only inactive pro-caspase 3
was found in RPTEC stimulated with TNFα. Only in cytochrome c treated cells activated caspase 3 was detected by western blot as shown in A, lane 2. Equal
loading was controlled by staining with actin. Location of DNaseI in the nuclei of RPTEC did not result in chromatin fragmentation as demonstrated by DNA
gel electrophoresis in B and TUNEL assay in C. DNA frommurine spleen incubated with 5μM camptothecin for 6 hrs was used as a positive control for
apoptotic DNA fragmentation (B, lane 2). No apoptotic DNA fragmentation was observed in DNA isolated from sham-stimulated RPTEC cells (B, lane 3) or in
DNA isolated from RPTEC after stimulation with 20ng/ml of TNFα for 48 hrs (B, lane 4). TUNEL-positive staining in RPTEC cells was detected only after
treatment with 10U of rhDNaseI (C, green). RPTEC cells stimulated with TNFα were TUNEL–negative as well as sham-stimulated cells as demonstrated in
C. Lane 1 in B represent DNA size markers.
doi:10.1371/journal.pone.0129485.g007
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Discussion
In this study we demonstrate 3 phenomena linked to expression of DNaseI. For the first, DNa-
seI is up-regulated most dominantly in early mesangial nephritis; secondly, experimentally in-
duced over-expression of DNaseI in RPTEC translocates DNaseI into the nucleus, and the
third, in human and murine lupus nephritis renal DNaseI is seen both in cytoplasm, as well as
in the nuclei of tubular cells. Increased renal DNaseI expression in mesangial nephritis and nu-
clear DNaseI translocation had its experimental analogy when showing the same phenomena
in tubular cells stimulated with TNFα and IL-1β, but not by hypoxic stress, nor by IFNγ, IL-6
or IL-10 in RPTEC. Therefore, up-regulation and nuclear translocation of the renal DNaseI
protein is a highly selective response to specific stimuli.
At a certain time point following mesangial nephritis the renal DNaseI mRNA, DNaseI pro-
tein and its enzyme activity are inevitably lost. We have demonstrated that acquired silencing
of the renal DNaseI gene expression appears to have a strong pathogenic impact on progressive
lupus nephritis [12–14,25]. The clinical consequence of renal DNaseI gene silencing is a pre-
dictable transformation of mild mesangial lupus nephritis into end-stage organ disease (re-
viewed in [10]). However, an up-regulation of renal DNaseI precedes DNaseI gene silencing
[25]. In this respect, three questions related to early lupus nephritis are regarded important to
answer; i. Why is the renal DNaseI gene up-regulated during mesangial nephritis? ii. Is the
term DNaseI unambiguously defined, or does DNaseI variants exist due to postsynthetic modi-
fications that may allocate DNaseI in different cell compartments in context of its up-regula-
tion? iii. Are all the variant of DNaseI proteins described here functional endonucleases?
Since there is a link between early mesangial nephritis and up-regulation of DNaseI, this
may be caused by the local effect of pro-inflammatory cytokines. Consistent with this idea,
stimulation of RPTEC with TNFα resulted in up-regulation of DNaseI, as shown by qPCR,
western blot analyses, and by confocal immunofluorescence microscopy. At the same time,
Trap 1 expression was reduced as demonstrated by western blots and confocal microscopy.
Thus, increased expression of DNaseI seems to reduce expression of Trap 1 most probably by
transcriptional interference of the two genes [29,31]. In an opposite context, these results may
indirectly indicate that up-regulation of Trap 1 in kidneys may down-regulate DNaseI expres-
sion (experiments in progression).
There are few descriptive studies on gene regulation by transcriptional interference in clini-
cal medicine. We have recently demonstrated an abrupt silencing of the DNaseI gene that cor-
related in time with up-regulation of Trap 1 in progressive lupus nephritis [29]. DNaseI is a
pro-apoptotic protein, as it degrades chromatin in dying cells [16,17]. Trap 1 is an anti-
apoptotic protein and is up-regulated during stress [27,38]. Trap 1 has anti-oxidant and anti-
apoptotic functions [28,39]. It is up-regulated during stress and inflammation [26,27], and
functions as a survival protein [40]. Trap 1 is up-regulated in different forms of cancers and
overexpression corresponds to an unfavorable prognosis [26,41–44]. In support to a role of
Trap 1 in cancer, studies based on oligonucleotide microarray demonstrated that Trap 1-posi-
tive cells contain high expression levels of genes that promote cell proliferation, compared with
Trap 1-negative cells, which had correspondingly low gene expression levels [45]. Previously,
we have shown that the ratio Trap 1/DNaseI was high to very high in Group 3 mice, where
DNaseI was correspondingly very weakly expressed [29]. In a reciprocal situation, up-
regulation of DNaseI may be followed by a down-regulation of Trap 1, in agreement with ob-
servations in this study.
Thus, the DNaseI and Trap 1 have opposite functions, as the first is involved in cell death,
and the other in cell-survival, and they have reciprocal expression patterns [29]. Our prelimi-
nary data on reciprocal expression of the two genes [29] are in agreement with experimental
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data on transcriptional interference [31,46,47]. However, in this study we dissected the inde-
pendent effects of TNFα and IL-1β on DNaseI and Trap 1 regulation. Our data indicate that
the regulation of these two proteins in the TNFα induced system involves other signal mole-
cules, like IL-1β. In this particular context DNaseI and Trap 1 regulation seems to be indepen-
dent from the proposed transcriptional interference model.
If DNaseI has the potential to exert other functions than as a major endonuclease has not
been determined. The results of studies on sub-cellular DNaseI location done by Peitsch et al.
[37] and Rauch et al. [33] suggested that the enzyme is translocated into the endoplasmic retic-
ulum, transported to Golgi apparatus and constantly secreted. Premature chromatin degrada-
tion due to accidental liberation of DNaseI from endoplasmic reticulum is protected by
binding to cytoplasmic actin that inhibits DNaseI activity. Nuclear location of DNaseI was ob-
served after induction of apoptosis. However, it is unclear how and why DNaseI reaches the
nucleus. It was proposed to occur due to passive diffusion through the nuclear pores or through
disrupted nuclear membranes during apoptosis [37].
In the present study we detected DNaseI in cytoplasm in resting RPTEC cell lines by confo-
cal microscopy. Interestingly, western blot analysis from total cell lysates or from BW kidneys
revealed two main protein bands: a strong 40 kDa and a weak 55 kDa band. Both of them were
identified as DNaseI by mass spectrometry. However, only the band corresponding to 40 kDa
was enzymatically active according to gel zymography on proteins extracted from BW kidneys.
Additional studies are required to identify the structure and function of the 55 kDa DNaseI
which is most probably a posttranslationally modified protein.
Stimulation of RPTEC with TNFα induced an increase of DNaseI protein expression and its
nuclear translocation. Western blot analysis of total cell lysate demonstrated up-regulation of
both 40 kDa and 55 kDa bands in RPTEC total cell lysate in response to TNFα. In order to
identify the origin of the two different protein bands we isolated nuclei and cytoplasm from
non-stimulated and stimulated RPTEC. Western blot analysis demonstrated that the 40 kDa
and the 55 kDa protein bands were found in cytoplasm only. Notably, the nuclear variant, the
52 kDa DNaseI protein had a size distinctly different from the former two of 40 and 55 kDa.
This nuclear-derived DNaseI was hardly detected in unstimulated cells but the expression of
this latter protein was strongly increased after TNFα stimulation. Therefore, the 52 kDa DNa-
seI protein corresponds solely to nuclear translocation of DNaseI. Interestingly, the DNaseI
translocation into the nuclei was not associated with increased DNaseI gene expression. This
was demonstrated by two experiments. IL-1β itself translocated DNaseI, but did not up-
regulate the DNaseI gene. This was confirmed when we simultaneously transfected the cells
with IL-1β siRNA and stimulated them with TNFα. This manipulation resulted in up-
regulation of the DNaseI gene expression, while the IL-1β siRNA prevented nuclear transloca-
tion. A firm conclusion is therefore that TNFα translocates DNaseI indirectly through the ef-
fect of TNFα-induced up-regulation of IL-1β [36]. These data allowed us to hypothesize that: i.
De novo synthesized DNaseI induced by TNFα is not translocated into the nucleus; ii. The nu-
clear 52 kDa sized DNaseI is most probably an IL-1β-induced modification of the cytoplasmic
40 kDa DNaseI, and iii. If the 40 kDa DNaseI is transformed into the nuclear 52 kDa DNaseI,
the modification transforms the active 40 kDa endonuclease into an endonuclease-inactive
DNaseI protein with a yet unkown function (studies in progress).
Since TNFα is a known inducer of apoptosis, our observation on nuclear translocation of
DNaseI one could interpret as a part of induced apoptotic cascade leading to apoptotic chro-
matin fragmentation. However, we did not observe signs of activated apoptosis in RPTEC
upon TNFα stimulation as demonstrated by absence of apoptotic DNA fragmentation,
TUNEL positive chromatin, activation of caspase 3 or morphological changes in RPTEC corre-
sponding to apoptosis. As has been published before, use of TNFα alone is not sufficient to
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induce apoptosis in RPTEC in vitro unless the cells are simultaneously treated with RNA and
protein syntheses inhibitors [48]. This is explained by the fact that TNFα triggers two distinct
signalling pathways leading either to apoptosis or to activation of NF-κB transcription factors
which will inhibit apoptosis through expression of anti-apoptotic genes [49–51]. On another
hand translocation of DNaseI in the RPTEC nuclei which was not accompanied by apoptotic
DNA fragmentation and appearance of TUNEL positive chromatin combined with the data
from gel zymography demonstrating that only the 40 kDa DNaseI was enzymatically active al-
lowed us to conclude that observed 52 kDa nuclear DNaseI in RPTEC had no enzymatic activi-
ty. The role of DNaseI variants and their translocation into the nucleus are real phenomena,
while their function in the nucleus basically remains to be established. In this sense, this may
open for new roles for DNaseI in cell biology. This is currently investigated in our laboratory.
Supporting Information
S1 Fig. DNaseI expression pattern in resting tubular cells by anti-DNaseI antibody from
Santa Cruz. Patterns of immunofluorescence staining of human renal proximal tubule epithe-
lial cells (RPTEC) and western blot analyses of RPTEC lysates are demonstrated. Anti-DNaseI
antibodies from Santa Cruz predominantly stain nuclei in resting RPTEC and recognize two
bands: 48 kDa and 50 kDa in western blot.
(TIF)
S2 Fig. DNaseI and Trap 1 expression in tubular cells after 24 hrs stimulation with TNFα
and IL-1β. Confocal microscopy of sham-stimulated human renal proximal tubule epithelial
cells (RPTEC) (A,C, upper panels) and cells stimulated with TNFα for 24 hrs (A, lower panels)
or with IL-1β (C, lower panels) was performed using anti-Trap1 antibodies (A and C, green)
and anti-DNaseI antibodies (A and C, red). After TNFα stimulation, the expression of DNaseI
was increased as demonstrated by anti-DNaseI antibodies on confocal microscopy (A, lower
panel versus upper panel, red), while Trap 1 protein expression decreased during stimulation
(A, lower panel compared with upper panel, green staining). Notably, we observed nuclear
translocation of DNaseI staining in the TNFα stimulated cells also after 24 hrs (A, lower panel
versus upper panel, C DNaseI is stained red)). The mRNA levels of DNaseI were increased
while Trap 1 mRNA levels remained unaffected (B). Nuclear translocation of DNaseI was also
observed after stimulation with IL-1β (C, lower panel versus upper panel, red), while mRNA
levels of Trap 1 and DNaseI were not significantly changed at this time point (D).
(TIF)
S3 Fig. DNaseI expression in RPTEC stressed by hypoxia and actin staining in RPTEC
stimulated with TNFα.Western blot analysis of RPTEC lysates demonstrated a weak increase
in DNaseI expression when comparing cells incubated at normoxia (lane 1) to cells after stress
by hypoxia for 48 hrs (lane 2). After 72 hrs of hypoxia the expression level of DNaseI was
markedly increased (lane 3 and lane 4 for normoxia and hypoxia respectively). Loading was
controlled by actin staining.
(TIF)
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